IR News

• 2024.09.30
  Release
  Submission of a Marketing Approval Application for the 2nd Biosimilar Product Developed under Alvotech Partnership
• 2024.09.24
  Release
  Approval for Alyssa® combination tablets (FSN-013),an estetrol-based drug, in Japan
• 2024.08.09
  Result
  Supplemental Materials of 3Q/FY2024 Consolidated Financial Results